Table 1.

Patient characteristics

	Sunitinib (n = 56)	Sorafenib (n = 47)	P‐value
Mean age (SD)	60 (8.2)	59 (9.6)	0.73
Men, no. %	39 (70%)	37 (79%)	0.12
Prior sunitinib therapy	–	10
Prior sorafenib therapy	19	–
Macrocytosis at baseline	0	0